Enterra Medical, Inc.

Enterra Medical, Inc. is a medical device company established in 2022, dedicated to helping individuals with chronic gastroparesis manage symptoms like nausea and vomiting. The company focuses on advancing technology and clinical science to enhance access to Enterra Therapy, a treatment originally developed by Medtronic and approved by the FDA in 2000. The flagship product, Enterra Therapy, is a gastric electrical stimulation system that uses an implantable neurostimulator to deliver mild electrical pulses to the stomach's nerves and muscles. This therapy is designed for adults aged 18 to 70 who experience chronic nausea and vomiting due to gastroparesis. Enterra Medical aims to improve patients' quality of life by providing a treatment option that goes beyond traditional methods like diet changes or surgery. The company also engages in clinical research to support and expand the understanding of Enterra Therapy, while emphasizing patient education and support throughout the treatment process.

• Employees 73
• Founded 2022